MedTrace Logo

Micro-hematology Analyzer for Viral/Bacterial Description

NCT05090319 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2021-11-03

No results posted yet for this study

Summary

The purpose of the study is to evaluate the reliability and accuracy of a newly developed point-of-care analyzer, theCytoTracker, to measure complete blood count (CBC) parameters and discriminate between viral and bacterial infections.

Conditions

  • Infection Viral
  • Infection, Bacterial

Interventions

DIAGNOSTIC_TEST

complete blood count

Complete blood count will be performed on the patient. Accuracy of micro-hematology analyzer will be assessed.

Sponsors & Collaborators

  • Baylor College of Medicine

    collaborator OTHER

  • RizLab Health, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-25
Primary Completion
2022-07-24
Completion
2022-07-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090319 on ClinicalTrials.gov